Emcure Pharmaceuticals Limited (NSE:EMCURE)
India · Delayed Price · Currency is INR 1,674.80
+31.80 (1.94%)
May 11, 2026, 3:30 PM IST
Emcure Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 9,244 | 6,813 | 4,982 | 5,320 | 6,622 |
Depreciation & Amortization | 4,150 | 3,743 | 3,032 | 2,512 | 2,348 |
Other Amortization | - | 97.98 | 92.56 | 89.04 | 100.28 |
Loss (Gain) From Sale of Assets | 2.34 | -382.35 | -71.92 | 3.33 | 4.08 |
Loss (Gain) From Sale of Investments | -15.24 | -58.04 | -25.32 | -1.21 | - |
Stock-Based Compensation | 28.29 | 19.89 | 39.67 | 52.76 | 57.16 |
Other Operating Activities | 1,327 | 2,526 | 2,419 | 2,415 | 1,469 |
Change in Accounts Receivable | -4,261 | -1,434 | -1,506 | -3,398 | -1,729 |
Change in Inventory | -3,838 | -4,067 | -267.61 | 663.85 | -3,072 |
Change in Accounts Payable | 2,765 | 1,702 | 1,543 | -391.8 | 3,157 |
Change in Other Net Operating Assets | 32.37 | -443.61 | 736.2 | 203.54 | -1,276 |
Operating Cash Flow | 9,435 | 8,517 | 10,972 | 7,469 | 7,682 |
Operating Cash Flow Growth | 10.78% | -22.38% | 46.91% | -2.78% | 9.05% |
Capital Expenditures | -3,606 | -2,218 | -2,758 | -3,906 | -3,782 |
Sale of Property, Plant & Equipment | 42.6 | 306.01 | 315.37 | 12.75 | 31.21 |
Cash Acquisitions | -7,249 | - | -3,451 | - | -2,751 |
Sale (Purchase) of Intangibles | -1,871 | -1,852 | -313.6 | -127.67 | -187.87 |
Investment in Securities | 734.94 | 2,592 | -1,098 | -708.36 | -1,308 |
Other Investing Activities | 17.72 | 231.44 | 179.46 | 152.4 | 109.49 |
Investing Cash Flow | -11,931 | -940.01 | -7,125 | -4,577 | -7,888 |
Short-Term Debt Issued | 4,303 | - | 1,025 | 976.79 | 1,759 |
Long-Term Debt Issued | 2,500 | - | 5,474 | 3,576 | 3,714 |
Total Debt Issued | 6,803 | - | 6,500 | 4,553 | 5,473 |
Short-Term Debt Repaid | - | -5,225 | - | - | - |
Long-Term Debt Repaid | -1,918 | -9,420 | -5,310 | -3,777 | -4,814 |
Total Debt Repaid | -1,918 | -14,645 | -5,310 | -3,777 | -4,814 |
Net Debt Issued (Repaid) | 4,884 | -14,645 | 1,190 | 775.24 | 659.17 |
Issuance of Common Stock | 66.46 | 7,792 | 76.6 | - | - |
Common Dividends Paid | -568.53 | - | -542.55 | -361.71 | -542.55 |
Other Financing Activities | -947.89 | -1,287 | -2,366 | -1,868 | -1,635 |
Financing Cash Flow | 3,434 | -8,140 | -1,642 | -1,454 | -1,519 |
Foreign Exchange Rate Adjustments | 181.55 | -20.49 | -20.02 | -1.28 | 1.86 |
Miscellaneous Cash Flow Adjustments | - | - | - | -100 | 2,141 |
Net Cash Flow | 1,121 | -583.02 | 2,185 | 1,336 | 418.7 |
Free Cash Flow | 5,830 | 6,299 | 8,215 | 3,563 | 3,900 |
Free Cash Flow Growth | -7.45% | -23.32% | 130.58% | -8.65% | -32.65% |
Free Cash Flow Margin | 6.33% | 7.98% | 12.34% | 5.95% | 6.66% |
Free Cash Flow Per Share | 30.76 | 33.68 | 45.42 | 19.70 | 21.57 |
Cash Interest Paid | - | 1,287 | 2,082 | 1,786 | 1,553 |
Cash Income Tax Paid | - | 2,469 | 2,237 | 2,005 | 3,112 |
Levered Free Cash Flow | 3,164 | 2,777 | 3,670 | 1,625 | 2,297 |
Unlevered Free Cash Flow | 4,062 | 3,591 | 4,940 | 2,781 | 3,216 |
Change in Working Capital | -5,301 | -4,243 | 505.17 | -2,922 | -2,919 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.